Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I-Ting Wu

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|August 10, 2024
Formononetin Defeats Multidrug-Resistant Cancers by Induction of Oxidative Stress and Suppression of P-GlycoproteinYing-Tzu Chang, I-Ting Wu, Ming-Jyh Sheu, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Pinostrobin and Tectochrysin Conquer Multidrug-Resistant Cancer Cells via Inhibiting P-Glycoprotein ATPaseI-Ting Wu, Chan-Yen Kuo, Ching-Hui Su, et al.
Bio-Medical Materials and Engineering|October 5, 2018
Dopant-dependent tailoring of physicochemical and biological properties of calcium silicate bone cementsI-Ting Wu, Ting-Yi Chiang, Chun-Cheng Chen, et al.
Journal of Materials Chemistry. B|June 6, 2022
Antibacterial ability and osteogenic activity of polyphenol-tailored calcium silicate bone cementI-Ting Wu, Ying-Hung Chu, Yun-Ru Huang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 25, 2023
Mosloflavone from Fissistigma petelotii ameliorates oncogenic multidrug resistance by STAT3 signaling modulation and P-glycoprotein blockadePo-Yu Chien, Yu-Hsuan Lan, I-Ting Wu, et al.
Journal of Drug Targeting|February 25, 2026
Natural triterpenoid glycosides, astragaloside II and astragaloside IV resensitize multidrug-resistant cancer via interfering ATPase activity and inducing apoptosis <i>in vitro</i> and <i>in vivo</i>Ying-Tzu Chang, Po-Yu Chien, Ching-Hui Su, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 6, 2025
Novel dihydrochalcone from Fissistigma latifolium targets STAT3 and survivin to overcome multidrug resistance cancers in vitro and in vivoI-Ting Wu, Ying-Tzu Chang, Ching-Hui Su, et al.
Gut|March 6, 2026
Optimising mono-antibiotic eradication regimen by potent acid inhibitor and bismuth: a potential solution to rising clarithromycin resistance in <i>Helicobacter pylori</i>Yu-Hwa Liu, I-Ting Wu, Tzung-Jiun Tsai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 19, 2021
Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sitesYu-Ning Teng, Bo-Hau Huang, Shih-Ya Huang, et al.
Psychiatry Research|February 16, 2010
The association between the harm avoidance subscale of the Tridimensional Personality Questionnaire and serotonin transporter availability in the brainstem of male volunteersI Ting Wu, I Hui Lee, Tzung Lieh Yeh, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|August 10, 2024
Formononetin Defeats Multidrug-Resistant Cancers by Induction of Oxidative Stress and Suppression of P-GlycoproteinYing-Tzu Chang, I-Ting Wu, Ming-Jyh Sheu, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Pinostrobin and Tectochrysin Conquer Multidrug-Resistant Cancer Cells via Inhibiting P-Glycoprotein ATPaseI-Ting Wu, Chan-Yen Kuo, Ching-Hui Su, et al.
Bio-Medical Materials and Engineering|October 5, 2018
Dopant-dependent tailoring of physicochemical and biological properties of calcium silicate bone cementsI-Ting Wu, Ting-Yi Chiang, Chun-Cheng Chen, et al.
Journal of Materials Chemistry. B|June 6, 2022
Antibacterial ability and osteogenic activity of polyphenol-tailored calcium silicate bone cementI-Ting Wu, Ying-Hung Chu, Yun-Ru Huang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 25, 2023
Mosloflavone from Fissistigma petelotii ameliorates oncogenic multidrug resistance by STAT3 signaling modulation and P-glycoprotein blockadePo-Yu Chien, Yu-Hsuan Lan, I-Ting Wu, et al.
Journal of Drug Targeting|February 25, 2026
Natural triterpenoid glycosides, astragaloside II and astragaloside IV resensitize multidrug-resistant cancer via interfering ATPase activity and inducing apoptosis <i>in vitro</i> and <i>in vivo</i>Ying-Tzu Chang, Po-Yu Chien, Ching-Hui Su, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 6, 2025
Novel dihydrochalcone from Fissistigma latifolium targets STAT3 and survivin to overcome multidrug resistance cancers in vitro and in vivoI-Ting Wu, Ying-Tzu Chang, Ching-Hui Su, et al.
Gut|March 6, 2026
Optimising mono-antibiotic eradication regimen by potent acid inhibitor and bismuth: a potential solution to rising clarithromycin resistance in <i>Helicobacter pylori</i>Yu-Hwa Liu, I-Ting Wu, Tzung-Jiun Tsai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 19, 2021
Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sitesYu-Ning Teng, Bo-Hau Huang, Shih-Ya Huang, et al.
Psychiatry Research|February 16, 2010
The association between the harm avoidance subscale of the Tridimensional Personality Questionnaire and serotonin transporter availability in the brainstem of male volunteersI Ting Wu, I Hui Lee, Tzung Lieh Yeh, et al.
Pageof 5